|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | c/o Brian T. Hildreth |
Address2 | 455 Capitol Mall, Suite 600 |
City | Sacramento |
State | CA |
Zip Code | 95814 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 40006052-12
|
||||||||
|
6. House ID# 397410000
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brian Hildreth |
Date | 7/20/2016 7:03:03 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Proposed Policy, Payment, and Quality Provisions Changes to the Medicare Physician Fee Schedule for Calendar Year 2017 (CMS-1654-P)
California Medicare Geographic Payment Locality Update Implementation (CMS-1654-P)
Medicare Access and Childrens Health Insurance Reauthorization Act Implementation (MACRA): Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models; Proposed Rule (CMS-5517-P)
Medicare Part B Physician Drug Payment Model Demonstration Project (March 11, 2016)
California Palliative Care Medical Home Medicare Pilot Project
Medicaid Managed Care Regulation
Medicare Recovery Audit Contractors (H.R. 3081)
MACRA Implementation
California Medicare Geographic Payment Locality Implementation
High Cost of Prescription Drugs - Requiring Pharma to Negotiate Drug Prices for Medicare Part D
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
McNeil |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Public Service Loan Forgiveness Program Regulation for California Doctors
17. House(s) of Congress and Federal agencies Check if None
Education - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
McNeil |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Comprehensive Addiction and Recovery Act (S 524) Conference Report
Zika Virus Response Funding (HR 2577)
Mental Health Programs and Policies (HR 2646)
Health Savings Accounts (HR 1270)
National All Schedules Prescription Electronic Reporting Act (S. 480/HR 1725)
Mental Health Reform Act of 2016 (S 2680)
Recovery Enhancement for Addiction Treatment Act (S. 1455)
The Co-Prescribing Saves Lives Act of 2016 (S. 2256)
The Plan of Safe Care Improvement Act (S. 2687)
The Partial Fill Amendment within the Managers Amendments to S 2680
Comprehensive Addiction and Recovery Act (S. 524)
Comprehensive Opioid Abuse Reduction Act (HR 5046)
Interagency Opioid Task Force (HR 4641)
The Opioid Use Disorder Treatment Expansion and Modernization Act (HR 4981)
Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act - Veterans Administration (HR 4063)
Good Samaritan Assessment Act (HR 4058)
Opioid Program Evaluation (OPEN) Act (HR 5022)
Infant Plan of Safe Care Improvement Act (HR 4843)
Nurturing and Supporting Healthy Babies Act (HR 4978)
Improving Treatment for Pregnant and Postpartum Women Act (HR 3691)
Ensuring Removal of Terminated Providers from Medicaid & CHIP (H.R. 3716)
Medication Assisted Treatment for Opioid Use Disorders (SAMHSA, RIN 0930-AA22)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
McNeil |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Advanced Practice Registered Nurses Scope of Practice (RIN 2900-AP44)
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
McNeil |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |